EU regulator rejects Alzheimer's drug lecanemab

"I am sure we will now see rich people with early Alzheimer’s disease flying to the US or other jurisdictions for treatment," says Professor Sir John Hardy (UCL Queen Square Institute of Neurology) who is critical of the EU's decision.

Listen: BBC Radio 4 ‘PM’ (from 20 mins 10 secs), Read: BBC News, More: The Sun, Telegraph (£), Financial Times (£)